Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of changes in the interests of Directors, Persons Discharging Managerial Responsibility or Connected Persons in the Ordinary shares of GlaxoSmithKline plc in respect of the under-mentioned persons arising from the purchase of Ordinary shares at a price of £12.94 per Ordinary share on 7 October 2010 through the Company's Share Reward Plan ("the Plan") which the under-mentioned persons entered on 5 October 2001:
Mr A P Witty |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr J S Heslop |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S M Bicknell |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr E J Gray |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr S A Hussain |
Acquisition of 6 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Dr D Pulman |
Acquisition of 10 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr D S Redfern |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Ms C Thomas |
Acquisition of 28 Ordinary shares under the Dividend Reinvestment element of the Plan
|
Mr P J T Vallance |
Acquisition of 11 Ordinary shares under the Dividend Reinvestment element of the Plan
|
The Company and the above-mentioned persons were advised of this information on 8 October 2010.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Deputy Company Secretary
8 October 2010